| answer text |
<p>Operational Delivery Networks (ODNs) provide expert specialist oversight of prescribing
decisions on hepatitis C. Funding has been provided via Commissioning and Quality
Innovation Payment (CQUIN) and it is NHS England’s intention to continue with CQUIN
funding in 2016/17 and 2017/18.</p><p> </p><p>When a patient attends NHS services
for treatment of hepatitis C, their attendance is included in the national tariff.</p><p>
</p><p>Depending on the specific nature of their healthcare need, their care may be
paid for by clinical commissioning groups (CCGs) or by NHS England’s specialised services
hubs according to coding and whether the care they receive is defined as a prescribed
specialised service.</p><p> </p><p>Some patients may have aspects of their hepatitis
C treatment provided by other services (such as drugs and alcohol services) which
are not funded by the NHS.</p><p> </p><p>NHS England is the responsible commissioner
for hepatitis C drugs. These are high cost drugs and so are excluded from the national
tariff.</p><p> </p><p>NHS England’s plan for future hepatitis C funding is being finalised
at the moment. As NHS England are working with ODN clinical leads to plan to ensure
that patients with unmet clinical need are treated via hepatitis C ODNs in a planned
way over the coming years.</p><p><strong> </strong></p>
|
|
